Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
43%(3 trials)

Phase Distribution

Ph phase_1
1
13%
Ph phase_2
1
13%
Ph phase_3
5
63%

Phase Distribution

1

Early Stage

1

Mid Stage

5

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
5(71.4%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(7)

Detailed Status

Completed7
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 21 (14.3%)
Phase 35 (71.4%)

Trials by Status

completed788%
not_yet_recruiting113%

Recent Activity

0 active trials
Showing 5 of 8
not_yet_recruiting

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

NCT06926647
completedphase_3

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

NCT04534725
completedphase_2

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

NCT00363649
completedphase_3

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

NCT00006237
completedphase_3

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

NCT00065468
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT06926647

A Real-World Study of Antiviral Therapy in Children With Chronic Hepatitis B

Not Yet Recruiting
NCT04534725Phase 3

COVID-19 Prevention and Treatment in Cancer; a Sequential Multiple Assignment Randomised Trial;

Completed
NCT00363649Phase 2

Interferon and GM-CSF Compared With Imatinib Mesylate and Vaccine Therapy in Patients With Chronic Phase CML on a TKI

Completed
NCT00006237Phase 3

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

Completed
NCT00065468Phase 3

Study Evaluating Interferon And CCI-779 In Advanced Renal Cell Carcinoma

Completed
NCT00005615Phase 1

Post-Operative Adjuvant Radiotherapy With Concurrent Interferon-Alfa

Completed
NCT00291369Phase 3

Cytokines in Patients With Metastatic Renal Cell Carcinoma of Intermediate Prognosis

Completed
NCT00004804Phase 3

Phase III Randomized Study of High Vs Standard Dose of Interferon Alfa for Chronic Hepatitis C

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8